Opinion: Accomplishments Over Accolades

Award-seeking and career-building behavior is contributing to the rise of bad science.

Written byNikolai Slavov
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, WARBURGThe more that scientists focus on awards and advertise career-building, the more that we, as a community, attract people seeking prizes and glamorous careers, and the bigger the burden on the peer review system. The independent and critical assessment of data and of analysis is at the core of our profession. Yet, the rapid growth of the scientific enterprise and the explosion of the scientific literature have made it all but impossible to read, think deeply, and assess independently even the subset of all published papers that is relevant to one’s research. This is alarming.

Here I suggest an approach to alleviating the problem, starting with two related questions: Why is low-quality “science” written up and submitted for publication, and what can we do to curb such submissions? These questions touch on the difficult-to-quantify subject of human motivation. Scientists have a complex set of incentives that include understanding nature, developing innovating solutions to important problems, and aspirations of heightened social status, prestige, and successful careers. These incentives have always existed and always will.

Scientific culture can powerfully affect the incentives of scientists and in the process harness the independent thought of the individual scientists—not only the external reviewers—in raising the standards and rigors of their work. I see a culture focused on prizes and career-building as inimical to science. If ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies